Weijia Hou
Papers
1
Total Citations
63
H-Index
1
About
Weijia Hou is a leading researcher in the field of nanomedicine and drug delivery, with a primary focus on the development and characterization of lipid-based nanoparticles for nucleic acid therapeutics. Hou’s most significant contribution to date is the development of an automated, high-throughput platform for the preparation and characterization of oligonucleotide-loaded lipid nanoparticles (LNPs), a breakthrough detailed in their highly cited 2021 paper (63 citations). This work addresses a critical bottleneck in LNP research by enabling rapid, reproducible, and scalable production of these complex formulations, which are essential for delivering mRNA, siRNA, and other genetic medicines. By integrating microfluidic mixing with real-time analytical characterization, Hou’s system dramatically accelerates the optimization of LNP formulations, paving the way for faster translation of gene therapies from bench to bedside. This innovative approach has positioned Hou as a key figure in the advancement of LNP manufacturing, with their work directly supporting the development of next-generation vaccines and targeted therapeutics.
Research Focus
Key Achievements
Top Papers
- 1